Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Trial of Cerclage Versus 17 α-Hydroxyprogesterone Caproate for Treatment of a Short Cervix

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ultrasonographic evidence of premature dilatation of the internal os~* Prolapse of the chorio-amniotic membranes into the endocervical canal~* Functional cervical length less than 25mm~* Exacerbation of these ultrasound findings with transfundal and/or suprapubic pressure~Exclusion Criteria:~* Any fetal chromosomal or structural anomaly~* Multiple gestation~* Known allergy to progesterone~* Ruptured membranes~* Vaginal bleeding~* Intra-amniotic infection (diagnosed clinically or by amniocentesis)~* Prolapse of endocervical membranes beyond the external cervical os~* Persistent uterine activity accompanied by cervical change~* Obstetrically indicated delivery.

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): McDonald cerclage
- 2 (Type: ACTIVE_COMPARATOR): 17 hydroxyprogesterone caproate

Based on this trial design, predict the completion outcome and termination type (if applicable).